Literature DB >> 10472154

A review of health-related quality-of-life concepts and measures for Parkinson's disease.

A M Damiano1, C Snyder, B Strausser, M K Willian.   

Abstract

Parkinson's disease affects individuals health-related quality of life (HQL). Including standardized HQL assessments in therapeutic clinical trials will broaden our understanding of treatment efficacy. Selecting appropriate HQL measures for clinical studies requires consideration of their comprehensiveness, psychometric properties and feasibility. To facilitate selection, this manuscript reviews the HQL areas affected by Parkinson's disease and available Parkinson's disease-specific HQL measures: the Parkinson's Disease Questionnaire--39 (PDQ-39) and the Parkinson's Disease Quality-of-Life Questionnaire (PDQL). Based on a literature review and consultation with HQL experts, five clinicians and three patients, 12 areas of HQL were identified as particularly relevant to Parkinson's disease: physical function, mental health/emotional well being, self-image, social function, health-related distress, cognitive function, communication, sleep and rest, eating, role function, energy/fatigue, and sexual function. The PDQ-39 measures all areas except for self-image and sexual function. The PDQL measures all areas except for eating and role function. Both measures are brief and are designed and validated to be self-completed by patients. Both measures demonstrate adequate internal consistency (PDQ-39: 0.72-0.95; PDQL: 0.80-0.87) and evidence of cross-sectional validity with patient-reported measures of similar concepts. The PDQ-39 also demonstrates reproducibility (0.68-0.94), significant associations with clinical measures and preliminary evidence of responsiveness. Applications of the PDQ-39 and PDQL to clinical trials will contribute greatly towards their continued validation and interpretation.

Entities:  

Mesh:

Year:  1999        PMID: 10472154     DOI: 10.1023/a:1008823222574

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  16 in total

1.  The MOS social support survey.

Authors:  C D Sherbourne; A L Stewart
Journal:  Soc Sci Med       Date:  1991       Impact factor: 4.634

2.  A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease.

Authors:  M Sano; Y Stern; K Marder; R Mayeux
Journal:  Mov Disord       Date:  1990       Impact factor: 10.338

3.  Desirable properties for instruments assessing quality of life: evidence from the PDQ-39.

Authors:  R Fitzpatrick; C Jenkinson; V Peto; N Hyman; R Greenhall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

4.  The MOS short-form general health survey. Reliability and validity in a patient population.

Authors:  A L Stewart; R D Hays; J E Ware
Journal:  Med Care       Date:  1988-07       Impact factor: 2.983

5.  Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the short-form health survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39)

Authors:  C Jenkinson; V Peto; R Fitzpatrick; R Greenhall; N Hyman
Journal:  Age Ageing       Date:  1995-11       Impact factor: 10.668

6.  An evaluation of the Alexander Technique for the management of disability in Parkinson's disease--a preliminary study.

Authors:  C Stallibrass
Journal:  Clin Rehabil       Date:  1997-02       Impact factor: 3.477

7.  Quality of life in patients with Parkinson's disease: development of a questionnaire.

Authors:  A G de Boer; W Wijker; J D Speelman; J C de Haes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

8.  The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score.

Authors:  C Jenkinson; R Fitzpatrick; V Peto; R Greenhall; N Hyman
Journal:  Age Ageing       Date:  1997-09       Impact factor: 10.668

9.  Health-related quality of life in Parkinson's disease: a study of outpatient clinic attenders.

Authors:  R Fitzpatrick; V Peto; C Jenkinson; R Greenhall; N Hyman
Journal:  Mov Disord       Date:  1997-11       Impact factor: 10.338

10.  Parkinson's disease and anxiety: comorbidity with depression.

Authors:  M A Menza; D E Robertson-Hoffman; A S Bonapace
Journal:  Biol Psychiatry       Date:  1993-10-01       Impact factor: 13.382

View more
  40 in total

1.  Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments.

Authors:  J Marinus; C Ramaker; J J van Hilten; A M Stiggelbout
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

Review 2.  Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.

Authors:  R C Dodel; K Berger; W H Oertel
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

3.  Axial rigidity and quality of life in patients with Parkinson's disease: a preliminary study.

Authors:  Roberto Cano-de-la-Cuerda; Lydia Vela-Desojo; Juan Carlos Miangolarra-Page; Yolanda Macías-Macías; Elena Muñoz-Hellín
Journal:  Qual Life Res       Date:  2010-12-14       Impact factor: 4.147

4.  Quality of life in Parkinson's disease: Greek translation and validation of the Parkinson's disease questionnaire (PDQ-39).

Authors:  Z Katsarou; S Bostantjopoulou; V Peto; A Alevriadou; G Kiosseoglou
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

5.  Quality of life in Parkinson's disease patients: validation of the Short-Form Eight-item Parkinson's Disease Questionnaire (PDQ-8) in Taiwan.

Authors:  Tzu-Ting Huang; Hua-Yun Hsu; Bi-Hwa Wang; Kang-Hua Chen
Journal:  Qual Life Res       Date:  2010-10-24       Impact factor: 4.147

6.  Relationships between clinical characteristics and nocturnal cardiac autonomic activity in Parkinson's disease.

Authors:  Naima Covassin; Ariel B Neikrug; Lianqi Liu; Jeanne Maglione; Loki Natarajan; Jody Corey-Bloom; Jose S Loredo; Barton W Palmer; Laura S Redwine; Sonia Ancoli-Israel
Journal:  Auton Neurosci       Date:  2012-11-08       Impact factor: 3.145

Review 7.  The effect of deep brain stimulation on quality of life in movement disorders.

Authors:  A Diamond; J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

8.  Neuroticism and extraversion in association with quality of life in patients with Parkinson's disease.

Authors:  Tatiana Dubayova; Iveta Nagyova; Eva Havlikova; Jaroslav Rosenberger; Zuzana Gdovinova; Berrie Middel; Jitse P van Dijk; Johan W Groothoff
Journal:  Qual Life Res       Date:  2008-11-07       Impact factor: 4.147

9.  Behind the mask : a study on the clinical course, psychopathology and impact on quality of life in idiopathic Parkinson's disease.

Authors:  Neena S Sawant; S R Parkar; Heena R Merchant; Avinash A De Sousa; S H Ravat
Journal:  Indian J Psychiatry       Date:  2004-10       Impact factor: 1.759

10.  SF-36 includes less Parkinson Disease (PD)-targeted content but is more responsive to change than two PD-targeted health-related quality of life measures.

Authors:  Carlos A Brown; Eric M Cheng; Ron D Hays; Stefanie D Vassar; Barbara G Vickrey
Journal:  Qual Life Res       Date:  2009-08-28       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.